Clinical Neurology and Neuroscience

Submit a Manuscript

Publishing with us to make your research visible to the widest possible audience.

Propose a Special Issue

Building a community of authors and readers to discuss the latest research and develop new ideas.

Research Article |

Clinical and Evaluative Profile of Guillain-Barré Syndrome in Burkina Faso: Retrospective Study of 49 Patients Collected in 16 Years (2003-2018)

Introduction: The aim of our study was to describe the epidemiological, paraclinical and clinical profile of Guillain-Barré syndrome (GBS) in the University Hospitals of Ouagadougou, Burkina Faso. Patients and methods: This was a retrospective, multicenter, descriptive study of the records of patients hospitalized for GBS in 3 Ouagadougou University Hospitals for a period of 16 years, from March 2003 to May 2018. Included in the study were the records of patients aged ≥ 16 years who were hospitalized for GBS during the study period, according to the modified Brighton diagnostic criteria. Patients who were HIV-positive or had cytorachy > 10 elements/mm3 were not included. Socio-demographic, climatic, clinical variables, Electroneuromyography (ENMG) data, cerebro spinal fluid (CSF) examination and evolution were studied. The intra-hospital clinical course of patients was assessed according to the Guillain-Barré Disability Scale (GBDS). Results: A total of 49 cases of GBS were hospitalized. The average age was 36 years, with a predominance of females (51%) and during the cold dry season (40.8%). In the state phase, all patients had a motor deficit of all 4 limbs and 15 patients (30.6%) had dysautonomia. The mean durations of the extension and plateau phases were 10 days and 19 days respectively. At the ENMG, the axonal form (71.4%) predominated. Pulmonary infection (36.7%), exacerbation of hypertension (32.6%) and electrolyte disorders (23%) were the most frequently encountered intra-hospital complications. Intra-hospital mortality was 18.4%. Among the survivors, 30% were confined to a wheelchair with or without respiratory assistance. After univariate analysis, intra-hospital infectious complications (p=0.04), exposure to mechanical ventilation (p=0.05) and severe clinical presentations (p=0.005) were the variables significantly influencing intra-hospital mortality. Conclusion: GBS affects more often young patients, occurs more frequently in the cold dry season. It is characterized by a late hospitalization of the patients, a predominant axonal damage. Early admission of patients, early use of quality intensive care units, availability of Polyvalent Intravenous immunoglobulin and plasma exchange, will significantly improve the prognosis of GBS in Burkina Faso and Sub-Saharan Africa (SSA).

Guillain-Barré Syndrome, Dysautonomy, Cold Dry Season, Mortality, Burkina Faso

APA Style

Labodi Lompo, D., M P Kaboré, R., Mariam Ouédraogo, A., Cissé, K., Ramdé, A., et al. (2023). Clinical and Evaluative Profile of Guillain-Barré Syndrome in Burkina Faso: Retrospective Study of 49 Patients Collected in 16 Years (2003-2018). Clinical Neurology and Neuroscience, 7(3), 56-64.

ACS Style

Labodi Lompo, D.; M P Kaboré, R.; Mariam Ouédraogo, A.; Cissé, K.; Ramdé, A., et al. Clinical and Evaluative Profile of Guillain-Barré Syndrome in Burkina Faso: Retrospective Study of 49 Patients Collected in 16 Years (2003-2018). Clin. Neurol. Neurosci. 2023, 7(3), 56-64. doi: 10.11648/j.cnn.20230703.13

AMA Style

Labodi Lompo D, M P Kaboré R, Mariam Ouédraogo A, Cissé K, Ramdé A, et al. Clinical and Evaluative Profile of Guillain-Barré Syndrome in Burkina Faso: Retrospective Study of 49 Patients Collected in 16 Years (2003-2018). Clin Neurol Neurosci. 2023;7(3):56-64. doi: 10.11648/j.cnn.20230703.13

Copyright © 2023 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License ( which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

1. van Doorn P A. Diagnosis, treatment and prognosis of Guillain-Barré syndrome (GBS). Presse Med. 2013; 42: e193–e201.
2. Garric JR, Conard M, Louis G, Bernard D et al. Le Syndrome de Guillain Barré en Réanimation: Réanimation (2014) 24: S92-S95.
3. Hughes RA, Cornblath DR. Guillain-Barré syndrome. Lancet 2005; 366: 1653-66.
4. Delannoy A, Rudant J, Chaignot C, et al. Incidence du syndrome de Guillain Barré en France: une analyse épidémiologique à partir des données du PMSI (2008-2013). Revue épidémiologique et Santé Publique; vol 65 N°S1 mars 2017 PS7. (5).
5. Pinol-Ripoll G, Larrodé P P, Garces-Redondo M, & Iñiguez C M. (2008, March). Characteristics of Guillain-Barré syndrome in the healthy area III of Aragon Country. In Anales de medicina interna 2008; (Vol. 25, No. 3, pp. 108-112).
6. Xu X, Shen D Li T, Zhang B, Mao M et al. (2016). Distinct Clinical Characteristics of Pediatrics Guillain Barre Syndrome: A comparative Study betwen children and adults in Northeast China. PLoS One 2016; 11 (3): e0151611.
7. Yuki N, Hartung HP. Guillain-Barré syndrome. N Engl J Med 2012; 366: 2294.
8. Habib R, Saifuddin M, Islam R, Rahman A et al: Clinical Profile of Guillain Barré Syndrome-Observations from a tertiary Care Hospital of Bangladesh. Birdem Med J 2017; 7 (1): 38-42.
9. Dhadke SV, Dhadke VN, Bangar SS, Korade MB. Clinical profile of Guillain Barré syndrome. J Assoc Physisian India 2013; 61 (3): 168-72.
10. Melaku Z, Zenebe G, & Bekele A. Guillain-Barré syndrome in Ethiopian patients. Ethiopian medical journal 2005; 43 (1), 21-26.
11. Howlett W P, Vedeler CA, Nyland H, & Aarli J A. Guillain-Barré syndrome in northern Tanzania: a comparison of epidemiological and clinical findings with western Norway. Acta neurologica scandinavica 1996, 93 (1), 44-49.
12. Sejvar JJ, Kohl KS, Gidudu J, Amato A, BakshiN, Baxter R, Burwen DR, Cornblath DR, Cleerbout J, Edwards KM, Heininger U. Guillain–Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 2011 Jan 10; 29 (3): 599–612.
13. Bahemuka M. Guillain-Barre syndrome in Kenya: a clinical review of 54 patients; J Neurol (1988) 235: 418-421.
14. Kassimi E H, Abdelfettah Y, Elbouchikhi M, Khadir A, Naitkhchat A, Lmidmani F, & Elfatimi A. Handicap et devenir fonctionnel après un syndrome de Guillain-Barré (expérience du service de Casablanca): à propos de 19 cas. Annals of Physical and Rehabilitation Medicine 2013; (56), e17.
15. Forsberg A, Press R, de Pedro-Cuesta J, Widéon Holmqvist L. Use of health-care, patient satisfactionand burden of care in Guillain-Barré syndrome Journal of Rehabilitation Medecine 2006; 38: 230-236.
16. Wong AH, Umapathi T, Shahrizaila N, Chan YC, Fong MK et al. The mortality of comparing mortality of Guillain Barré syndrome across different regions. J Neurol Sci. 2014 Sep 15; 344 (1-2): 60-2.
17. van KR, van Doorn PA, Schmitz PI, Ang CW, van der Meche FG. Mild forms of Guillain-Barre syndrome in an epidemiologic survey in The Netherlands. Neurology 2000 Feb 8; 54 (3): 620-5.
18. Chan LY, Tsui MH, Leung TN. Guillain-Barre syndrome in pregnancy. Acta Obstet Gynecol Scand 2004 Apr; 83 (4): 319-25.
19. Vaduva C, de Seze J, Volatron AC, Stojkovic T, Piechno S, Husson J, et al. Syndrome de Guillain-Barré sévère et grossesse: deux cas d’amélioration rapide en post partum. Rev Neurol (Paris) 2006 Mar; 162 (3): 358-62.
20. De Pedro Cuesta J, Abraira V, Jiang GX, et al. Guillan Barre syndrome in south-west Sockholm, 1973-1991. 3. Clinicoepidemilogical subgroups. Acta Neurol Scand 1996; 93: 175-83.
21. Ishaque T, Islam M B, Ara G, Endtz H P, Mohammad Q D, Jacobs B C, & Islam Z. High mortality from Guillain-Barré syndrome in Bangladesh. Journal of the Peripheral Nervous System 2017, 22 (2), 121-126.
22. Islam B, Islam Z, Rahman S, et al. Small volume plasma exchange for Guillain Barré Syndrome in resource-limited setting: a phase II safety and feasability study. BMJ Open 2018; 8: e022862. Doi: 10.1136/bmjopen-2018-022862.
23. Ho TW, Mishu B, Li CY, et al. Guillain-Barré syndrome in northern China: relationship to Campylobacter jejuni and anti-glycolipid antibodies. Brain 1995; 118 (Pt 3): 597-605.
24. Ogawara K, Kuwabara S, Mori M, et al. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan. Ann Neurol 2000; 48 (4): 624-31.
25. Kuwabara S. Guillain-Barré syndrome: epidemiology, pathophysiology and management. Drugs 2004; 64 (6): 597-610.
26. Yuki N. Acute motor axonal neuropathy and multifocal motor neuropathy: more in common than not. Muscle Nerve 2013; 48: 693-5.
27. Durand MC, Porcher R, Orlikowski D, Clair CD, Annane D, JeanLouis Gaillard JL et al. Clinical and electrophysiological predictors of respiratory failure in Guillain-Barre Syndrome: a prospective study. The Lancet Neurology 2006; 5: 1021-1028.
28. Dhar R, Stitt L, Hahn AF. The morbidity and outcome of patients with Guillain-Barré syndrome admitted to the intensive care unit. J Neurol Sci. 2008; 264: 121-8.
29. Verma R, Chaudhari T S, Raut T P, & Garg R K. Clinico-electrophysiological profile and predictors of functional outcome in Guillain–Barre syndrome (GBS). Journal of the neurological sciences 2013, 335 (1-2), 105-111.
30. Roshan K, Al-Futaisi A, Chacko A, Fazalullah M, Al Nabhani S, Al-Awaidy S,... & Al-Mahrooqi S. Clinical Characterisstics of Childhood Guillain Barré Syndrome. Oman Medical journal july 2008; volume 13, Issue 3.
31. Hu M-H, Chen C-M, Lin-Lin K et al. Risk Factors of Respiratory Failure in Children with Guillain-Barré Syndrome: Pediatrics and neonathology 2012; 53, 295-299.
32. Islam Z, Jacobs B C, van Belkum A, Mohammad Q D, Islam M B, Herbrink P,... & Endtz H P. Axonal variant of Guillain-Barre syndrome associated with Campylobacter infection in Bangladesh. Neurology 2010, 74 (7), 581-587.
33. Kalita J, Misra U K, Goyal G, & Das M. (2014). Guillain-Barré syndrome: subtypes and predictors of outcome from India. Journal of the Peripheral Nervous System 2014; 19 (1), 36-43.
34. Ashekhlee A, Hussain Z, Sultan B, & Katirji B. Guillain–Barré syndrome: incidence and mortality rates in US hospitals. Neurology 2008; 70 (18), 1608-1613.
35. Van den Berg B, Bunschoten C, van Doorn PA, Jacobs BC. Mortality in Guillain-Barré syndrome. Neurology. 2013; 80: 1650 4.
36. Orlikowski D, Sharshar T, Porcher R, Annane D, Raphael JC, Clair B. Prognosis and risk factors of early onset pneumonia in ventilated patients with Guillain-Barré syndrome. Intensive Care Med. 2006; 32: 1962 9.
37. Netto AB, Taly AB, Kulkarni GB, Uma Maheshwara Rao G S, Rao S. Prognosis of patients with Guillain-Barré syndrome requiring mechanical ventilation. Neurol India [serial online] 2011 [cited 2016 Apr 7]; 59: 707-11.
38. Domínguez-Moreno R, Tolosa-Tort P, Patiño-Tamez A, Quintero-Bauman A, Collado-Frías D K, Miranda-Rodríguez M G,... & Estañol-Vidal B. Mortalidad asociada al diagnóstico de síndrome de Guillain-Barré en adultos ingresados en instituciones del sistema sanitario mexicano. Rev Neurol 2014; 58 (1), 4-10.